Oestrogen therapies comprised hormone replacement therapies, combined oral contraceptives, and topical vaginal oestrogen preparations
Oestrogen therapies comprised hormone replacement therapies, combined oral contraceptives, and topical vaginal oestrogen preparations. with contamination risk for SGLT2i, in contrast to DPP4i where risk increased with higher HbA1c. One-year complete risk of genital contamination with SGLT2i was highest for those with a history of prior contamination (females 23.7%, males 12.1%), compared with those without…
Read more